Companies/Allurion Technologies Inc.

Company profile

Allurion Technologies Inc.

OTC: ALUR · Healthcare · Medical - Devices

PublicHQ Natick, MACIK 0001964979Reports USD

#580 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

27D

FH 30DQ 17GM 30SS 42

v0.1 · 65/100 weight · provisional

↑ workforce scale, Piotroski F · ↓ balance-sheet leverage, disclosure history

Methodology →

Revenue TTM

$12.6M

Rev growth YoY (TTM)

-55.5%

Net income (FY)

-$28.8M

Employees

134

Market cap

$4.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$15.2M$15.2M2025

Net income-$28.8M-$28.8M2025

Operating income-$30.2M-$30.2M2025

Total assets$15.8M$15.8M2025

Liabilities$93.0M$93.0M2025

Equity-$77.2M-$77.2M2025

Revenue trend

FY2023 – FY2025 · USD

$64.2M

FY23

$53.5M

FY23

$9.4M

FY24

$21.2M

FY24

$26.5M

FY24

$32.1M

FY24

$15.2M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Allurion Technologies Inc. booked $15.2M in FY2025 revenue, contracting 53% year over year — slower than 83% of Healthcare companies we track, at a -188.8% net margin.

Peers · Healthcare

Kane Biotech Inc.24D Soligenix, Inc.42D Biotricity, Inc.——MedX Health Corp28D

Key facts

CEOShantanu K. Gaur

SectorHealthcare

IndustryMedical - Devices

HeadquartersNatick, MA

ExchangeOTC: ALUR

Employees134

IPO date2021-03-29

Latest filings

8-K2026-07-07 8-K2026-06-30 8-K2026-06-17 8-K2026-05-27 10-Q2026-05-15 10-K2026-03-30 8-K2026-03-12 8-K2026-03-02

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.